HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yue Lu Selected Research

safranal

1/2021Safranal Alleviated OVA-Induced Asthma Model and Inhibits Mast Cell Activation.
1/2020Safrana l Prevents Prostate Cancer Recurrence by Blocking the Re-activation of Quiescent Cancer Cells via Downregulation of S-Phase Kinase-Associated Protein 2.
1/2019Safranal Alleviates Dextran Sulfate Sodium-Induced Colitis and Suppresses Macrophage-Mediated Inflammation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yue Lu Research Topics

Disease

74Neoplasms (Cancer)
07/2022 - 01/2008
26Inflammation (Inflammations)
12/2021 - 01/2010
14Prostatic Neoplasms (Prostate Cancer)
01/2022 - 05/2011
14Lymphoma (Lymphomas)
12/2020 - 11/2012
13Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
06/2022 - 01/2017
12Leukemia
01/2021 - 08/2005
11Psoriasis (Pustulosis Palmaris et Plantaris)
01/2021 - 07/2016
10Multiple Myeloma
05/2022 - 08/2015
10Carcinogenesis
01/2019 - 08/2011
9Brain Injuries (Brain Injury)
06/2022 - 01/2017
9Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2021 - 08/2011
8Anaphylaxis (Anaphylactic Shock)
01/2021 - 12/2011
7Asthma (Bronchial Asthma)
01/2021 - 09/2009
6Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
06/2021 - 06/2012
6Necrosis
01/2021 - 12/2014
6T-Cell Lymphoma (Lymphoma, T Cell)
11/2020 - 01/2013
6Neoplasm Metastasis (Metastasis)
01/2019 - 12/2004
6Infections
10/2018 - 03/2007
6Extranodal NK-T-Cell Lymphoma
05/2016 - 01/2015
5Stroke (Strokes)
10/2022 - 12/2016
5Hypoxia (Hypoxemia)
07/2022 - 01/2017
5Fibrosis (Cirrhosis)
07/2022 - 11/2019
5Melanoma (Melanoma, Malignant)
03/2022 - 11/2016
5Parkinson Disease (Parkinson's Disease)
01/2022 - 01/2021
5Body Weight (Weight, Body)
01/2021 - 01/2013
5Traumatic Brain Injuries (Traumatic Brain Injury)
01/2021 - 01/2018
5Breast Neoplasms (Breast Cancer)
01/2020 - 03/2014
5Colitis
12/2019 - 01/2017
4Pancreatic Neoplasms (Pancreatic Cancer)
07/2022 - 06/2017
4Ischemic Stroke
10/2021 - 12/2016
4Brain Ischemia (Cerebral Ischemia)
01/2021 - 12/2016
4Hypersensitivity (Allergy)
01/2021 - 03/2012
4Disease Progression
01/2020 - 01/2011
4BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
02/2014 - 08/2005
4Insulin Resistance
08/2013 - 01/2013
3Hyperplasia
01/2021 - 07/2016
3Neurodegenerative Diseases (Neurodegenerative Disease)
01/2018 - 12/2015
3Colonic Neoplasms (Colon Cancer)
11/2016 - 12/2004
3Residual Neoplasm
05/2016 - 02/2012

Drug/Important Bio-Agent (IBA)

27Proteins (Proteins, Gene)FDA Link
03/2022 - 10/2007
16Biomarkers (Surrogate Marker)IBA
05/2022 - 01/2012
14CytokinesIBA
01/2021 - 08/2005
12Pharmaceutical PreparationsIBA
01/2022 - 01/2010
11DNA (Deoxyribonucleic Acid)IBA
12/2020 - 06/2009
10RNA (Ribonucleic Acid)IBA
12/2021 - 01/2014
9Asparaginase (Elspar)FDA Link
01/2018 - 07/2012
8Glucose (Dextrose)FDA LinkGeneric
01/2021 - 01/2013
7Biological ProductsIBA
01/2022 - 08/2005
7Immunoglobulin E (IgE)IBA
01/2021 - 10/2010
7Messenger RNA (mRNA)IBA
11/2019 - 09/2009
6Therapeutic UsesIBA
01/2022 - 06/2010
6MicroRNAs (MicroRNA)IBA
02/2021 - 11/2016
6OvalbuminIBA
01/2021 - 09/2009
6Imiquimod (Aldara)FDA LinkGeneric
01/2021 - 07/2016
5Interleukin-6 (Interleukin 6)IBA
01/2021 - 01/2019
5Small Interfering RNA (siRNA)IBA
01/2021 - 03/2014
5Indicators and Reagents (Reagents)IBA
03/2018 - 09/2015
5AMP-Activated Protein KinasesIBA
09/2014 - 01/2013
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2022 - 08/2010
4LigandsIBA
05/2022 - 12/2014
4LipidsIBA
01/2022 - 07/2013
4IntegrinsIBA
10/2021 - 02/2014
4pegaspargase (Oncaspar)FDA Link
11/2020 - 05/2016
4EnzymesIBA
06/2020 - 02/2016
4Phosphotransferases (Kinase)IBA
01/2020 - 02/2013
4Doxorubicin (Adriamycin)FDA LinkGeneric
01/2019 - 11/2012
4Transcription Factors (Transcription Factor)IBA
01/2019 - 07/2009
4Oxaliplatin (Eloxatin)FDA LinkGeneric
06/2016 - 03/2014
4GemcitabineFDA Link
06/2016 - 03/2014
4Anti-Allergic Agents (Antiallergic Agents)IBA
01/2016 - 12/2011
4kirenolIBA
02/2014 - 09/2011
3Tyrosine Kinase InhibitorsIBA
01/2022 - 05/2015
3AntioxidantsIBA
01/2021 - 01/2019
3Interleukin-17 (Interleukin 17)IBA
01/2021 - 04/2019
3safranalIBA
01/2021 - 01/2019
3InterleukinsIBA
01/2021 - 09/2009
3Neuroprotective AgentsIBA
01/2021 - 01/2019
3Sirtuin 1IBA
01/2021 - 01/2019
3InterferonsIBA
01/2021 - 08/2005
3coactivator-associated arginine methyltransferase 1IBA
12/2020 - 01/2018
3Androgen Receptors (Androgen Receptor)IBA
01/2020 - 01/2018
3CollagenIBA
12/2019 - 11/2019
3CurcuminIBA
01/2019 - 07/2012
3Toll-Like Receptor 4IBA
01/2019 - 03/2018
3VaccinesIBA
01/2019 - 11/2010
3Phenobarbital (Luminal)FDA Link
01/2018 - 09/2016
3Phosphopyruvate Hydratase (Enolase)IBA
01/2018 - 09/2012
3AcidsIBA
02/2016 - 10/2014
3Interleukin-5 (Interleukin 5)IBA
01/2016 - 09/2009

Therapy/Procedure

45Therapeutics
10/2022 - 08/2005
19Drug Therapy (Chemotherapy)
01/2021 - 03/2010
10Radiotherapy
07/2022 - 08/2010
10Hematopoietic Stem Cell Transplantation
01/2022 - 03/2010
8Transplantation
01/2021 - 03/2010
7Castration
12/2019 - 01/2016
6Immunotherapy
01/2020 - 06/2012
5Deep Brain Stimulation
01/2022 - 01/2021
3Electrodes (Electrode)
01/2022 - 01/2021
3Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2021 - 01/2020
3Chemoradiotherapy
11/2020 - 06/2008